In a 14‑day‑old infant with jaundice whose serum bilirubin rose from 161 µmol/L to 280 µmol/L over three days despite normal feeding and stools, what management is indicated?

Immediate Phototherapy is Required

This 14-day-old infant with a bilirubin of 280 µmol/L (approximately 16.4 mg/dL) requires immediate phototherapy initiation. The rising bilirubin despite initial decline indicates either ongoing hemolysis or inadequate bilirubin clearance, and at this level, there is risk of bilirubin neurotoxicity 1.

Why This Infant Needs Treatment Now

At 14 days of age with a bilirubin of 280 µmol/L, this infant has crossed the threshold for phototherapy intervention. The concerning trajectory—initial decline from 161 to 124 µmol/L followed by a sharp rise to 280 µmol/L over 3 days—suggests either:

• Ongoing hemolysis (ABO/Rh incompatibility, G6PD deficiency, hereditary spherocytosis)
• Inadequate conjugation or excretion (Gilbert syndrome, Crigler-Najjar, hypothyroidism)
• Breast milk jaundice (though less likely given the rapid rise)

The fact that the infant is feeding well and having normal stools does NOT eliminate the risk of bilirubin neurotoxicity 1, 2.

Immediate Actions Required

1. Start Phototherapy Immediately

• Use blue LED phototherapy (460-490 nm wavelength, preferably 478 nm peak) at irradiance of 25-35 µW/cm²/nm 1
• Position the light source to maximize skin exposure
• Expect bilirubin to decrease within 4-6 hours of initiation 1
• Continue phototherapy until bilirubin drops below treatment threshold (typically when it falls to approximately 50-70 µmol/L below the phototherapy initiation threshold)

2. Urgent Investigations to Identify the Cause

• Direct/conjugated bilirubin - Critical at 14 days to rule out cholestasis and biliary atresia 3
• Complete blood count with reticulocyte count - assess for hemolysis
• Blood type and Coombs test (if not already done) - ABO/Rh incompatibility
• G6PD level - especially if male or high-risk ethnicity
• Thyroid function tests - hypothyroidism causes prolonged jaundice
• Peripheral blood smear - look for spherocytes or other red cell abnormalities

3. Monitor Response

• Recheck total serum bilirubin in 4-6 hours after starting phototherapy 1
• If bilirubin continues to rise or fails to decline, consider:
  • Intensifying phototherapy (increase irradiance, add second light source)
  • Preparing for possible exchange transfusion if approaching 340-425 µmol/L (20-25 mg/dL) depending on risk factors 2

Critical Pitfall: Prolonged Jaundice at 14 Days

Any infant still jaundiced at 14 days MUST have conjugated bilirubin measured 3. If >20% of total bilirubin is conjugated (or >34 µmol/L), this indicates cholestatic liver disease, potentially biliary atresia, which requires urgent hepatobiliary imaging and surgical referral. Missing biliary atresia beyond 60 days of life significantly worsens outcomes.

Why Normal Feeding and Stools Don't Reassure

While adequate feeding and stooling are positive signs, they do not protect against bilirubin neurotoxicity at these levels. Kernicterus can occur in well-appearing, feeding infants if bilirubin reaches neurotoxic levels 1, 4. The blood-brain barrier vulnerability persists in the first weeks of life.

Do NOT Interrupt Breastfeeding

If the infant is breastfeeding, continue breastfeeding during phototherapy 5. Interrupting breastfeeding increases the risk of permanent breastfeeding cessation and is not necessary for effective phototherapy. Ensure adequate hydration and caloric intake, but maintain breastfeeding.

Follow-Up After Phototherapy

Once phototherapy is discontinued (when bilirubin falls sufficiently below threshold), recheck bilirubin in 24 hours to ensure no rebound hyperbilirubinemia 2, 6. Given the rising pattern in this infant, close surveillance is essential.